Literature DB >> 4073850

Preservation of hypothalamic dopaminergic neurons in Parkinson's disease.

M M Matzuk, C B Saper.   

Abstract

The integrity of the hypothalamic neuroendocrine dopaminergic neurons in Parkinson's disease was assessed by comparing the numbers and distribution of melanin-pigmented neurons in the arcuate and periventricular nuclei in 7 parkinsonian and 5 normal brains. No significant differences were observed. In contrast to theories suggesting that Parkinson's disease involves a universal degeneration of central catecholaminergic neurons, the hypothalamic neuroendocrine dopaminergic neurons do not appear to be involved by the disease.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4073850     DOI： 10.1002/ana.410180507

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


  22 in total

1.  Molecular basis for catecholaminergic neuron diversity.

Authors:  Jan Grimm; Anne Mueller; Franz Hefti; Arnon Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-07       Impact factor: 11.205

Review 2.  Neuromelanin of the human substantia nigra: an update.

Authors:  Fabio A Zucca; Emy Basso; Francesca A Cupaioli; Emanuele Ferrari; David Sulzer; Luigi Casella; Luigi Zecca
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

Review 3.  Pattern of brain destruction in Parkinson's and Alzheimer's diseases.

Authors:  H Braak; E Braak; D Yilmazer; R A de Vos; E N Jansen; J Bohl
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 4.  The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.

Authors:  D J Surmeier; J N Guzman; J Sanchez-Padilla; P T Schumacker
Journal:  Neuroscience       Date:  2011-08-25       Impact factor: 3.590

Review 5.  Circadian and sleep disorders in Parkinson's disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Exp Neurol       Date:  2012-08-23       Impact factor: 5.330

Review 6.  Calcium, bioenergetics, and neuronal vulnerability in Parkinson's disease.

Authors:  D James Surmeier; Paul T Schumacker
Journal:  J Biol Chem       Date:  2012-10-19       Impact factor: 5.157

7.  The hypothalamus of the human adult: chiasmatic region.

Authors:  H Braak; E Braak
Journal:  Anat Embryol (Berl)       Date:  1987

Review 8.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

9.  FosB and ΔFosB expression in brain regions containing differentially susceptible dopamine neurons following acute neurotoxicant exposure.

Authors:  Joseph R Patterson; Elizabeth J Kim; John L Goudreau; Keith J Lookingland
Journal:  Brain Res       Date:  2016-08-24       Impact factor: 3.252

Review 10.  Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease.

Authors:  D James Surmeier; Jaime N Guzman; Javier Sanchez-Padilla
Journal:  Cell Calcium       Date:  2010-01-06       Impact factor: 6.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.